, and this has usually been surgical decompression ; however, when treatment has been given by external deep x-ray therapy the majority of such patients have shown improvement in their visual-field defects (Fraser and Joplin, 1961) . Where the presenting syndrome comprises only acromegaly and the other effects of excessive growth-hormone secretion the need for treatment may seem less obvious. The activity of acromegaly is difficult to assess, and the natural history of the untreated disease is not adequately known. Bishop and Briggs (1958) Acromegaly has in the past been treated by surgical removal of the tumour or by external deep x-ray therapy, and, more recently, by heavy-particle irradiation (Lawrence et al., 1962) . As an alternative to these methods we have used needle implantation of radioactive seeds, with the intention of delivering a heavier dose of irradiation to the pituitary than is feasible by external deep x-ray therapy: the objective is the destruction of the overactive growth-hormone-secreting cells while not impairing normal pituitary function. To supplement the preliminary results of such treatment (Joplin et al., 1961b) this paper reports our more extended experience, and also our assessment of the relative usefulness of several parameters for the assessment of the activity of acromegaly.
Partial Pituitary Ablation with Implants of and The ideal -method for the treatment of acromegaly remains uncertain. Evidence of local pressure from a pituitary tumour offers an absolute indication for treatment, and this has usually been surgical decompression ; however, when treatment has been given by external deep x-ray therapy the majority of such patients have shown improvement in their visual-field defects (Fraser and Joplin, 1961) . Where the presenting syndrome comprises only acromegaly and the other effects of excessive growth-hormone secretion the need for treatment may seem less obvious. The activity of acromegaly is difficult to assess, and the natural history of the untreated disease is not adequately known. Bishop and Briggs (1958) Acromegaly has in the past been treated by surgical removal of the tumour or by external deep x-ray therapy, and, more recently, by heavy-particle irradiation (Lawrence et al., 1962) . As an alternative to these methods we have used needle implantation of radioactive seeds, with the intention of delivering a heavier dose of irradiation to the pituitary than is feasible by external deep x-ray therapy: the objective is the destruction of the overactive growth-hormone-secreting cells while not impairing normal pituitary function. To supplement the preliminary results of such treatment (Joplin et al., 1961b) this paper reports our more extended experience, and also our assessment of the relative usefulness of several parameters for the assessment of the activity of acromegaly.
Subjects Treated
Twenty-eight patients have been treated by implantation. These consisted of all the subjects recently referred in whom the clinical picture (Table I) and tests (Table II) The augmented insulin-tolerance test (Fraser et al., 1962 
Implantation Technique
The main features of the technique have been described (Joplin et al., 1961b (Kelly et al., 1951 ; Buys and Kerns, 1957) , and from our experience with total pituitary ablation for disseminated breast cancer that a dose of at least 100,000 rads was required to destroy pituitary tissue, it was decided to use a dose giving 10,000 rads to the periphery of the gland, which is thus less than a tenth of the dose we use for a total pituitary ablation. In the initial series (Joplin et al., 1961b) unchanged. Recently the dose has been increased again, and '0Y alone is being implanted with a planned peripheral dose of 20,000 rads.
The dose plans for the nine patients who had reimplants were decided for various reasons as follows: six implants of 90Y alone, four with planned peripheral doses of 100,000 rads, one of 10,000 rads, and one of 1,000 rads. Three patients had mixed implants of "98Au and 90Y, with a planned total peripheral dose of 10,000 rads, half being contributed from each source.
Results Preimplant State Table I shows some of the clinical features of 28 patients who were subsequently implanted. Only two had field defects; one defect was a slight bitemporal hemianopia, and the other was a unilateral central scotoma due to a macular degeneration and unrelated to the acromegaly. The results of the investigations done on these patients are shown in Table II . It will be seen that half of those tested were diabetic or " pre-diabetic " by the criterion of an abnormal prednisone glycosuria test. The great majority were insulinresistant, the values of " the insulin-resistance index " for the two exceptions being borderline (134 and 136). Half of those tested had a raised urinary calcium level, but only four had a raised serum-inorganic-phosphate level. There was one patient whose pituitary fossa was not recognizably abnormal on x-ray examination. In the remainder the abnormality was visible on the plain lateral and antero-posterior views of the fossa; the most usual abnormality was an enlargement of the fossa, often with a double contour, indicating this enlargement to be asymmetrical. Lateral tomography, performed for the purpose of exact planning of the implant, defined these abnormalities more precisely. Effect on pituitary function.- Table IV shows the state of the other functions of the pituitary after the final implantation in the 22 patients. With regard to menstruation, one woman who had had no periods for 12 months resumed regular periods after operation, three who were menstruating regularly before operation continued unchanged, while two others developed amenorrhoea. Of these latter, one was a woman aged 47 whose periods stopped after the first implant, while the other had had a second implant deliberately planned to ablate the pituitary. Seven patients required thyroxine and corticosteroid maintenance therapy: in two this was a sequel of a second implant designed to destroy the pituitary, and in five of infection in the pituitary after operation. In addition, there were two patients in whom neither of these factors existed yet who became steroid-dependent two and three years after operation. Complications.-Thirty-nine implants were done on 28 patients, and complications were encountered in 11 patients. There were four instances of cerebrospinal-fluid leak, of which two subsided spontaneously; in the other two a stainless-steel screw was inserted in the hole in the fossa wall, which was effective in one, while the other finally required the surgical insertion of a muscle strip to seal the hole. Three patients developed meningitis, and five sustained pituitary abscesses. In two of these patients there had been a C.S.F. nasal drip, and it seems possible that some at least of the other cases developed their infection as sequelae to C.S.F. leaks which were not recognized. In one patient the pituitary infection proved fatal because of delayed treatment of the meningitis, but in the others it rapidly subsided after treatment with antibiotics. It Acromegaly-Hartog et al. MBRITSH
has proved necessary to continue the antibiotics for several months after the initial infection to avoid a relapse. There were two patients who developed visual complications; one was a woman who had severe pituitary infection following a second implant and developed blindness of one eye, which began nine months after operation. The other woman was found to have a cyst, but was nevertheless satisfactorily implanted, with a good regression of her acromegaly; 15 months later she developed bitemporal hemianopia. Both these patients were operated upon by Mr. M. Falconer, who found large empty sellae with numerous adhesions, and the optic chiasmas and optic nerves were found pulled into the sellae. Four patients developed diabetes insipidus, for which they required treatment with Pitressin; it was transient in three and permanent in one.
Discussion
It was our aim to give a sufficient dose of irradiation to the pituitary to produce a satisfactory remission of the disease, without producing hypopituitarism or endangering surrounding structures. The first objective has on the whole been attained; considerable and often striking remission of the disease usually followed the implant, and even some regression of bony acromegaly has been seen. On the other hand, hypopituitarism has not always been avoided, and some operative complications have followed. We hope that the present improved technique will lessen these disadvantages. The main hazard is that of either C.S.F. rhinorrhoea or infection, which we hope to minimize in future by using higher dosage 9gY implants, which may be self-sterilizing, and pre-operative nasal antibacterial sprays. Two patients developed late visual-field defects. Each was somewhat unusual; one had had a serious infection of the pituitary, and in the other a pituitary cyst had been encountered at operation. Perhaps these circumstances were responsible for the tethering of the surrounding structures to the pituitary surface, and so for their later subsidence into the fossa, resulting in damage to the optic nerve or chiasma by traction. While pituitary function was usually preserved after the implant so that no replacement therapy was needed, such therapy was required in seven patients, either because a second implant was planned to destroy the pituitary or because of post-operative pituitary infections, and in two others because hypopituitarism developed two to three years after the implant.
Alternative methods of treatment may be compared. Striking improvement of acromegaly, with regression of the acromegalic facies, has been reported following a maximal dosage of conventional deep x-ray therapy (Johnsen, 1952) , but this is rare. Reports of early surgical series, in which the procedure was restricted to removal of as much of the tumour as possible rather than total hypophysectomy (Henderson, 1939 ; Bakay, 1950) , showed that striking remission of the disease was unusual, and in one of the series (Henderson, 1939) (1959) reported significant regressions in all of their 10 patients who were subjected to total hypophysectomy via the transantrosphenoidal route without serious morbidity, and good results were also obtained by Ray (1960) . On the other hand, surgical mortality has been quite high in some series of operations for pituitary tumour; for instance, it was 16.4% in the series of Decker and Lauter (1960) , and even higher figures were quoted in their review; in addition, such total hypophysectomy necessarily makes the patient steroid-and thyroid-dependent.
The report of Lawrence et al. (1962) indicated that highenergy heavy-particle irradiation can also produce striking remissions in acromegaly; they obtained good results in 5 out of 15 patients, but three developed visual impairment. Pituitary implantation of 90Y seeds by Molinatti et al. (1962) , using seeds of much higher activity than those used in the present study, led to improvement in acromegalic features in 13 out of 16 patients, and the two patients with field defects were relieved of these. Cortisone therapy was required in only one case. They had no instances of pituitary infection, while in the present series 8 out of 39 implants were followed by this complication. Perhaps the more active 90Y rods exert a stronger self-sterilizing effect than those used in the present series.
It would seem that a higher dose of irradiation than that used for most of this series is required for optimal results. We are now using implants of 90Y alone, planned to give a peripheral dose of 20,000 rads. The limiting factor to the dosage which can be used will probably be the incidence of hypopituitarism rather than irradiation damage to surrounding structures.
Summary
Twenty-two patients with acromegaly have been assessed after therapeutic partial pituitary ablation by implantation of "98Au, 90Y, or both. Nine of the patients required second implants. The response to the treatment was classed as satisfactory in 13, partial in six, and not improved in three.
Other pituitary function was not impaired in 13 patients; corticosteroid and/or thyroxine dependency developed in nine, of whom two had had deliberate total pituitary destruction by a second implant and five a pituitary abscess. One patient developed permanent diabetes insipidus. Complications from a total of 39 implants (in 28 patients) consisted of eight cases of pituitary infection (one fatal), and four cerebrospinal fluid leaks (all recovered, one requiring surgical repair). Two patients developed late visual-field defects associated with retraction of the optic nerves into large empty sellae.
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